Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2025-12-27 @ 12:17 PM
Study NCT ID:
NCT01600092
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2012-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-14
First Submit QC Date:
None
Study First Post Date:
2012-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-09
Results First Submit QC Date:
None
Results First Post Date:
2015-03-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-14
Last Update Post Date Type:
ACTUAL